"Lack of clinically significant interference by spironolactone with the Axsym Digoxin II assay" only applies to low-dose therapy with spironolactone.

Title:: "Lack of clinically significant interference by spironolactone with the Axsym Digoxin II assay" only applies to low-dose therapy with spironolactone.
Document type:: Comment; Letter; Letter
Author(s):: Steimer, W
Journal title abbreviation:: Ther Drug Monit
Year:: 2003
Journal volume:: 25
Journal issue:: 4
Pages contribution:: 484-5
Language:: eng
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/12883235
Print-ISSN:: 0163-4356
TUM Institution:: Institut für Klinische Chemie und Pathobiochemie
BibTeX

Occurrences: